David Larsen
Stock Analyst at BTIG
(2.10)
# 2,870
Out of 4,944 analysts
76
Total ratings
35%
Success rate
-1.43%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLP Simulations Plus | Maintains: Buy | $41 → $25 | $14.53 | +72.06% | 3 | Jul 7, 2025 | |
| CYRX Cryoport | Maintains: Buy | $13 → $10 | $9.08 | +10.13% | 3 | Jul 7, 2025 | |
| DOCS Doximity | Upgrades: Buy | $80 | $64.02 | +24.96% | 2 | Jun 2, 2025 | |
| PGNY Progyny | Upgrades: Buy | $28 | $23.06 | +21.42% | 4 | Mar 31, 2025 | |
| HIMS Hims & Hers Health | Initiates: Buy | $35 | $48.33 | -27.58% | 1 | Jan 7, 2025 | |
| HQY HealthEquity | Maintains: Buy | $110 → $130 | $89.27 | +45.63% | 4 | Nov 14, 2024 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $30 → $31 | $26.71 | +16.08% | 3 | Nov 11, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $290 → $260 | $190.23 | +36.68% | 2 | Nov 1, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $15 → $20 | $22.39 | -10.67% | 2 | Oct 3, 2024 | |
| ASTH Astrana Health | Maintains: Buy | $60 → $70 | $29.69 | +135.77% | 1 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $3.93 | +78.12% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $279.18 | -14.03% | 1 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $1.73 | +304.62% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $6.89 | +103.19% | 3 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.10 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $31.35 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $45 | $8.97 | +401.67% | 4 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $21 | $3.22 | +552.17% | 3 | Sep 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.05 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $21.02 | +66.51% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.44 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $7.19 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $148.12 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $663.17 | -75.87% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $75 → $70 | $11.89 | +488.73% | 3 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $68.98 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $65.90 | +28.98% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $5.33 | +331.52% | 1 | Nov 2, 2017 |
Simulations Plus
Jul 7, 2025
Maintains: Buy
Price Target: $41 → $25
Current: $14.53
Upside: +72.06%
Cryoport
Jul 7, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $9.08
Upside: +10.13%
Doximity
Jun 2, 2025
Upgrades: Buy
Price Target: $80
Current: $64.02
Upside: +24.96%
Progyny
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $23.06
Upside: +21.42%
Hims & Hers Health
Jan 7, 2025
Initiates: Buy
Price Target: $35
Current: $48.33
Upside: -27.58%
HealthEquity
Nov 14, 2024
Maintains: Buy
Price Target: $110 → $130
Current: $89.27
Upside: +45.63%
Consensus Cloud Solutions
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $26.71
Upside: +16.08%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $190.23
Upside: +36.68%
BrightSpring Health Services
Oct 3, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $22.39
Upside: -10.67%
Astrana Health
Oct 3, 2024
Maintains: Buy
Price Target: $60 → $70
Current: $29.69
Upside: +135.77%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $3.93
Upside: +78.12%
Jul 9, 2024
Initiates: Buy
Price Target: $240
Current: $279.18
Upside: -14.03%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $1.73
Upside: +304.62%
Apr 23, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $6.89
Upside: +103.19%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $7.10
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $31.35
Upside: -
Oct 12, 2022
Maintains: Buy
Price Target: $55 → $45
Current: $8.97
Upside: +401.67%
Sep 26, 2022
Maintains: Buy
Price Target: $25 → $21
Current: $3.22
Upside: +552.17%
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $1.05
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $21.02
Upside: +66.51%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $7.44
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $7.19
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $148.12
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $663.17
Upside: -75.87%
May 23, 2018
Maintains: Market Perform
Price Target: $75 → $70
Current: $11.89
Upside: +488.73%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $68.98
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $65.90
Upside: +28.98%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $5.33
Upside: +331.52%